Case of cryptic TNIP1::PDGFRB rearrangement presenting with myelodysplastic syndrome achieved hematologic and cytogenetic remission with low-dose imatinib plus decitabine therapy.
Leuk Res Rep
; 19: 100367, 2023.
Article
in En
| MEDLINE
| ID: mdl-36968263
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Leuk Res Rep
Year:
2023
Type:
Article
Affiliation country:
China